Mérieux Développement SAS Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Mérieux Développement SAS has acquired 3 companies.

Mérieux Développement SAS’s most common sectors for investment are healthcare services (34%) and medical products (34%). The Firm’s most common investment types include secondary buyout (50%) and buyout (lbo, mbo, mbi) (34%). In total, Mérieux Développement SAS has invested in 1 US state and 4 different countries.

The Firm’s most common exit type is trade sale (50%).

Join Mergr to view Mérieux Développement SAS’s full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity6
    • M&A Sell Activity2
  • Total Sectors Invested 4
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 1
  • M&A Advisors 1

Mérieux Développement SAS

3, Rue Marcel Gabriel Rivière ,
Lyon, 69002
France
+33 4 78 87 37 00
www.merieux-developpement.com
info@merieux-developpement.com

Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.


Investment Criteria

Sectors of Interest: Healthcare Services, Medical Products

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Scandinavia, Middle East

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.8/yr) # 2 1 - 1 2 - 6
Sell (0.2/yr) # 1 1 - - - - 2
  8

Most Recent M&A

Company Date Value Type
Doc Generici Srl 2019-04-08 - Secondary Buyout
Milan, Italy · www.docgenerici.it
Nutragroup 2019-01-16 - Buyout (LBO, MBO, MBI)
Chambéry, France
Stiplastics SA 2018-01-18 - Secondary Buyout
Eauvoir En Royans, France · www.stiplastics.com
Novacap SAS 2016-03-21 - Secondary Buyout
Cedex, France · www.novacap.eu
Kalila Medical, Inc. 2016-02-05 - Add-on Acquisition
Campbell, California · www.kalilamedical.com
Advencis Sarl 2014-10-15 - Trade Sale - Public Company
Mutzig, France · www.advencis.com
Kalila Medical, Inc. 2014-10-01 - Buyout (LBO, MBO, MBI)
Campbell, California · www.kalilamedical.com
Lavorel Medicare SA 2013-05-23 - Growth Capital
Luxembourg, Luxembourg · www.lavorelmedicare.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Novacap SAS 2016-03-21 PCI Synthesis, Inc. 2018-06-20 2
Cedex, France · www.novacap.eu Newburyport, Massachusetts · www.pcisynthesis.com
Novacap SAS 2016-03-21 Chemoxy International Ltd. 2017-07-22 1
Cedex, France · www.novacap.eu Middlesbrough, United Kingdom · www.chemoxy.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 2 (40%) - 2 (33%) -
Medical Products 1 (20%) - 2 (33%) -
Chemicals 1 (20%) - 1 (17%) -
Life Science 1 (20%) - 1 (17%) -
Total 5 - 6 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
France 3 (60%) - 3 (50%) -
Italy 1 (20%) - 1 (17%) -
Luxembourg 1 (20%) - 1 (17%) -
United States - - 1 (17%) -
  California - - 1 (17%) -
Total 5 - 6 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Secondary Buyout 3 (60%) - 3 (50%) -
Buyout (LBO, MBO, MBI) 1 (20%) - 2 (33%) -
Growth Capital 1 (20%) - 1 (17%) -
Total 5 - 6 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (100%) -
Total 2 -

Top M&A Advisors

Legal Deals
White & Case LLP
1

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
3 100%
Exited to
Strategic(s)
100%
1 100%

 Subscribe to unlock this and 155,627
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.0K Private Equity Firms
  • 144K M&A Transactions
  • 152K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 45K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.